Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons

NeuroReport

Volumn 11, Issue 5, 2000, Pages 923-926

  Borlongan, Cesario V ^a   Su, Tsung Ping ^a   Wang, Yun ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

6 hydroxydopamine; Cell viability; Fetal mesencephalic cells; Hibernation medium; Parkinson's disease; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

DELTA OPIATE RECEPTOR; DELTAKEPHALIN; DOPAMINE TRANSPORTER; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; METHAMPHETAMINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; FETUS; MALE; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034615839     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004070-00005     Document Type: Article

References (26)

1. 1. Hauser RA, Freeman TB, Snow BJ et al. Arch Neurol 56, 179-187 (1999).
2. 2. Olanow CW, Freeman TB and Kordower JH. Adv Neurol 74, 249-269 (1997).
3. 3. Borlongan CV, Sanberg PR and Freeman TB. Lancet 353, 29-30 (1999).
4. 4. Espejo M, Cutillas B, Ventura F and Ambrosio S. Neurosci Lett 275, 13-16 (1999).
5. 5. Mehta V, Hong M, Spears J and Mendez I. J Neurosurg 88, 1088-1095 (1998).
6. 6. Sautter J, Tseng JL, Braguglia D et al. Exp Neurol 149, 230-236 (1998).
7. 7. Tsao LI, Cadet JL and Su TP. Eur J Pharmacol 372, 5-7 (1999).
8. 8. Tsao LI, Ladenheim B, Andrews AM et al. J Pharmacol Exp Ther 287, 322-331 (1998).
9. 9. Hayashi T, Tsao LI, Cadet JL and Su TP. Eur J Pharmacol 366, 7-8 (1999).
10. 10. Dunnett SB and Bjorklund A. Brain Res Protoc 1, 91-99 (1997).
11. 11. Kearns CM and Gash DM. Brain Res 672, 104-111 (1995).
12. 12. Borlongan CV, Stahl CE, Fujisaki T et al. Cell Transplant 8, 153-159 (1999).
13. 13. Coyle JT and Puttfarcken P. Science 262, 689-695 (1993).
14. 14. Stoessl AJ. Can J Neurol Sci 26, 5-12 (1999).
15. 15. Oeltgen PR, Nilekani SP, Nuchols PA et al. Life Sci 43, 1565-1574 (1988).
16. 16. Shibata S, Tominaga K and Watanabe K. Eur J Pharmacol 279, 197-202 (1995).
17. 17. Genovese RF, Moreton JE and Tortella FC. Brain Res Bull 34, 111-116 (1994).
18. 18. Woodburn VL, Oles R, Poat J et al. Neuroscience 56, 703-709 (1993).
19. 19. Hayward NJ, McKnight AT and Woodruff GN. Eur J Neurosci 5, 961-967 (1993).
20. 20. Chien S, Oeltgen PR, Diana JN et al. JThorac Cardiovasc Surg 107, 964-967 (1994).
21. 21. Oeltgen PR, Horton ND, Bolling SF and Su TP. Ann Thorac Surg 61, 1488-1493 (1996).
22. 22. Wu G, Zhang F, Salley RK et al. J Thorac Cardiovasc Surg 111, 259-267 (1996).
23. 23. Bolling SF, Su TP, Childs KF et al. Transplantation 63, 326-329 (1997).
24. 24. Kevelaitis E, Peynet J, Mouas C et al. Circulation 99, 3079-3085 (1999).
25. 25. Han J, Cheng FC, Yang Z and Dryhurst C. J Neurochem 73, 1683-1695 (1999).
26. 26. Prasad KN, Cole WC and Kumar B. J Am Coll Nutr 18, 413-423 (1999).